Summary:

FDA requirements vary during each stage of the drug development process but the ultimate goal is the delivery of safe and effective drug products in the marketplace.  

In this whitepaper, we examine the demands of quality management in the pre-clinical and clinical stages of drug development, the challenges quality assurance professionals and auditors face when managing clinical quality manually, and how technology can automate processes, streamline workflows and increase visibility for greater efficiency and safety.